英国的疫苗创新途径
Sarah Danson1,2,3, Robert P Jones3,4, Kristina Duggleby3
1Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom.
Immunotherapy advances
|January 12, 2026
概括
英国疫苗创新途径 (VIP) 显著促进了癌症疫苗研究,通过创新的试验交付,患者招募率增加了500%. 这项英国倡议加速了个性化癌症治疗和部署.
科学领域:
- 在瘤学瘤学.
- 疫苗学 疫苗学 疫苗学
- 临床试验 临床试验
背景情况:
- 癌症疫苗对瘤学具有重大前景,特别是随着mRNA技术的进步.
- 英国政府建立了英国疫苗创新途径 (VIP),以加快癌症疫苗研究,利用COVID-19疫苗计划的专业知识.
- VIP是英国国家卫生和护理研究所 (NIHR),英格兰国家卫生保健局 (NHS) 和制药公司的合作项目.
研究的目的:
- 概述英国疫苗创新路径 (VIP) 和癌症疫苗启动平台 (CVLP) 的战略框架,成果和经验教训.
- 展示如何创新的试验交付模式可以加速癌症疫苗研究和部署.
- 为未来国家实施个性化癌症治疗的战略提供信息.
主要方法:
- 该VIP实施了临床试验交付的创新方法,包括简化试验设置和分散的交付模式.
- 与癌症疫苗推出台 (CVLP) 的合作促进了许多NHS网站的患者预先查.
- 该计划的重点是以公平为重点的设计,以确保广泛的患者获取.
主要成果:
- 在癌症疫苗试验的患者招募中实现了500%的增加.
- 目前有33项试验正在开放或最近已结束,涵盖85个地点和11种不同类型的癌症.
- 展示了一个可扩展的,以患者为中心的模型,用于提供个性化的癌症疗法.
结论:
- 英国的方法有效地将科学创新与癌症疫苗的快速临床部署相结合.
- VIP和CVLP模型提供了一个可扩展和以患者为中心的框架,用于推进个性化癌症治疗.
- 从VIP和CVLP中吸取的经验教训可以指导未来的癌症疫苗部署和研究的国家战略.
相关概念视频
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Vaccinations
51.2K
Overview
51.2K
Cancer Vaccines
945
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
945
Microorganisms in Medicine and Therapeutics
925
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
925
Development of Immunocompetence
781
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
781
Biopharmaceutical Factors Influencing Drug Product Design: Overview
227
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
227


